Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0237300

While there are no antiviral drugs or effective vaccines against COVID-19 on the market; we leverage the existing knowledge of viroporins and structural modeling to explain a putative mechanism involving E protein in SARS-CoV-2 related infection. The development of therapeutic approaches is being hindered due to the lack of understanding of molecular mechanisms and players responsible for this novel viral infection [

Frankly, I think Biotron were ahead of their time investing all recourses on the E Protein, time will tell (hopefully not too long) but i i think investors will be rewarded in the near future!